Plasma kallistatin levels in patients with severe community-acquired pneumonia
Open Access
- 1 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 17 (1), R27
- https://doi.org/10.1186/cc12507
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort studyCritical Care, 2012
- Protection of the liver against CCl4-induced injury by intramuscular electrotransfer of a kallistatin-encoding plasmidWorld Journal of Gastroenterology, 2011
- Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational studyCritical Care, 2011
- Admission D-dimer Can Identify Low-Risk Patients With Community-Acquired PneumoniaAnnals of Emergency Medicine, 2009
- Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired PneumoniaAnnals of Emergency Medicine, 2008
- Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative StressHypertension, 2008
- The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumoniaThorax, 2007
- Beneficial effects of Kallikrein-binding protein in transgenic mice during endotoxic shockLife Sciences, 1997
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- APACHE IICritical Care Medicine, 1985